Dose normalization [Study Per­for­mance]

posted by Relaxation  – Germany, 2021-05-27 17:29 (1036 d 22:37 ago) – Posting: # 22373
Views: 1,900

❝ will not receive the actual dose, but will receive a smaller dose when assessing BD / BE (2x2x2) design)?


Hello yura.

I am sorry, but I am a little bit in a hurry and just wanted to start the answers here with one single comment.
As you are in a cross-over situation and assuming that the dose (BSA) of a subject will not change between periods, there is no need for a dose-adjustment with regard to the treatment comparison. Or the other way around: as you compare intraindividually the dose-adjustment would cancel out anyway.

Best regards!

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
117 visitors (0 registered, 117 guests [including 7 identified bots]).
Forum time: 15:06 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5